3//SEC Filing
Biosion, Inc. 3
Accession 0000929638-24-004038
CIK 0001557746other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 11:03 AM ET
Size
4.8 KB
Accession
0000929638-24-004038
Insider Transaction Report
Form 3
Biosion, Inc.
10% Owner
Holdings
Warrants (right to buy)
Exercise: $0.00From: 2024-11-18→ Common Stock (11,281,985 underlying)
Footnotes (1)
- [F1]On November 18, 2024, Aclaris Therapeutics, Inc. ("Aclaris") and Biosion, Inc. ("Biosion") entered into a Common Stock Purchase Warrant (the "Warrant"). Pursuant to the Warrant, Biosion, its designee or its permitted assigns, upon meeting certain terms and conditions of the Warrant, is entitled to exercise the warrant for up to 11,281,985 shares of Aclaris Common Stock. The Warrant was exercisable as of November, 18 2024 and may be exercised until the date on which the Warrant is exercised in full.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0002045933
Filing Metadata
- Form type
- 3
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 11:03 AM ET
- Size
- 4.8 KB